By: Sara Riascos  Apr. 26, 2022
Sepsis is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payors such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Cefuroxime is an antibiotic used to treat bacterial infections of the ear, nose, throat, lungs, skin, bones, joints, bladder, or kidneys. Studies have shown that Cefuroxime significantly reduced the frequency of sepsis after TRUSBP.
Dexur’s analysis of Real World Evidence based on Medicare Claims data showed that the use of Cefuroxime within 7 days of hospitalization was associated with lower hospital readmission rates for Sepsis Patients at UPMC Harrisburg Hospital in Harrisburg, Pennsylvania. Reduction in readmission rates helps hospitals improve their outcomes for various cost and quality programs. Dexur is an approved entity to perform Medicare claims data analysis, which it uses to perform quality outcomes analysis. Dexur has published several papers with Harvard Medical School on quality outcomes related topics. Dexur’s analysis of drugs and their impact on quality outcomes, such as readmissions and mortality, are used by Hospitals, IDNs, and ACOs to implement best practices and manage Real World Evidence based risk factors.
We conducted a retrospective study using Dexur’s analysis of Real World Evidence from Medicare Claims data, for hospitalizations at UPMC Harrisburg Hospital between January 2017 to September 2019. Our methodology criteria was as follows:
Overall, Cefuroxime was associated with lower hospital readmission rates for all Primary ICD Diagnosis Codes examined at UPMC Harrisburg Hospital. For patients whose primary ICD Diagnosis was “Sepsis, unspecified organism”(A419) and when Cefuroxime was used within 7 days of hospitalization, the readmission rate was 19.67% compared to the cohort where Cefuroxime was not used, whose readmission rate was 27.92%. The readmission odds ratio for these cohorts was 0.63. The use of Cefuroxime was associated with a 37% lower readmission rate when used within 7 days of hospitalization. The full list of studied ICD codes, readmission rates, odds ratios, confidence intervals, and percentage reduction in readmission with Cefuroxime at UPMC Harrisburg Hospital is shown below.
= Data Available for Premium Subscribers. Please email email@example.com for subscription information
|Primary ICD Diagnosis Code||Primary ICD Diagnosis Code Description||Total Hospitalizations without Cefuroxime||Readmission Without Cefuroxime||Readmission Rate without Cefuroxime||Total Hospitalizations with Cefuroxime||Readmission with Cefuroxime||Readmission Rate with Cefuroxime||Readmission Odds Ratio||Reduction in Readmission with Cefuroxime (%)||Confidence Interval (-)||Confidence Intervals (+)|
|A419||Sepsis, unspecified organism||2,414|
Dexur also leveraged Medicare claims data to understand what percentage of patients hospitalized with Sepsis were not prescribed Cefuroxime within 7 days of discharge.
|ICD CODE||Hospital||Hospitalizations with Sepsis||% of Hospitalizations without Cefuroxime|
|A419||UPMC Harrisburg Hospital||3,494||99.69%|
|Yale New Haven Hospital||3,816||99.63%|
Hospitalizations with Sepsis = Above Listed ICD Codes
If figures are shared with “At Least” - this implies that the drug utilization within 7 days post hospitalization is less than 11
According to analysis of Real World Evidence of Medicare Claims data, for hospitalizations between January 2017 to September 2019, the use of Cefuroxime within 7 days of hospitalization can lead to substantial reductions in hospital readmission rates of Sepsis patients at UPMC Harrisburg Hospital. This analysis shows that a significant number of Patients are not dispensed Cefuroxime after Sepsis hospitalizations at UPMC Harrisburg Hospital or major US Hospitals.